Metraipolis › archive › dc_c162b8a97c8f

Cost-Effectiveness Analysis of Recombinant Zoster Vaccine at Age 50 for Chinese Adults with Mild Cognitive Impairment: A Modelling Study — Europe PMC PMID:42188778

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42188778
DOI: 10.3390/vaccines14050406
License (as archived): solo-consultazione
Archived: 2026-11-02T20:21:16.893Z
SHA-256 of the archived text: 6416b90537fc9f31030289804ec4a97fb2ecadde8e7f8047bb524be3d68c8ed7
Stable URL of this page: https://metraipolis.com/documento/dc_c162b8a97c8f

How to cite

Cost-Effectiveness Analysis of Recombinant Zoster Vaccine at Age 50 for Chinese Adults with Mild Cognitive Impairment: A Modelling Study — Europe PMC PMID:42188778 — Europe PMC (en), https://europepmc.org/article/MED/42188778 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c162b8a97c8f (Metraipolis archive dc_c162b8a97c8f, sha256 6416b90537fc9f31030289804ec4a97fb2ecadde8e7f8047bb524be3d68c8ed7)

BibTeX

@misc{dcc162b8a97c8f,
  title = {Cost-Effectiveness Analysis of Recombinant Zoster Vaccine at Age 50 for Chinese Adults with Mild Cognitive Impairment: A Modelling Study — Europe PMC PMID:42188778},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42188778},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c162b8a97c8f; sha256 6416b90537fc9f31030289804ec4a97fb2ecadde8e7f8047bb524be3d68c8ed7},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42188778. Agents can read the archived copy with the MCP tool read_document.